Инсулин НПХ. Эффективность перемешивания - эффективность дозирования
Аннотация
Ключевые слова
Список литературы
1. Brostoff J.M., Keen Н., Brostoff J. A diabetic life before and after insulin era. Diabetologia 2007; 50: 1351-1353.
2. Alberti G. Lessons from the history of insulin. Diabetes Voice 2001; 46: 33-34.
3. Ozawa H., Murai Y., Ozawa T. A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus. Yakushigaku Zasshi 2003; 38: 1-27.
4. Laubach E., Schwandt P., Ritter M.M. Neutral protamine Hagedorn insulin. Lancet 2000; 355: 236.
5. Murnaghan J.H., Talalay P. John Jacob Abel and the crystallization of insulin. Persp Biol Med 1967; 10: 334-381.
6. Балаболкин М.И., Клебанова E.M., Креминская B.M. Лечение сахарного диабета и его осложнений. Медицина 2005; 512.
7. Heinemann L., Sinha К., Weyer С. et al. Time-action profile of the soluble, fatty acid acylated, long-acting insulin analogue NN304. Diabet Med 1999; 16: 332-338.
8. Scholtz H.E., Pretorius S.G., Wessels D.H., Becker R.H. Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using an euglycaemic clamp technique. Diabetologia 2005; 48: 1988-1995.
9. American Diabetes Association. Clinical practice recommendations. Diabetes Care 2009; 32: Suppl l: l-98.
10. Bantle J.P., Neal L., Frankamp L.M. Effects of the anatomical region used for insulin injections on glycemia in type 1 diabetes subjects. Diabetes Care 1993; 16: 1592-1597.
11. Thow J.C., Johnson A.B., Fulcher G., Home P.D. Different absorption of isophane (NPH) insulin from subcutaneous and intramuscular sites suggests a need to reassess recommended insulin injection technique. Diabet Med 1990; 7: 600-602.
12. Heinemann L. Variability of insulin absorption and insulin action. Diabetes Technol Ther 2002; 4: 673-682.
13. Hänel H., Weise A., Sun W. et al. Differences in the dose accuracy of insulin pens. J Diabetes Sci Technol 2008; 2: 478-481.
14. Jorgensen J.O., Flyvbjerg A., Jorgensen J.T. et al. NPH insulin administration by means of a pen injector. Diabet Med 1998; 55: 574-576.
15. Fisken R.A., Goulbourn J. Treatment of insulin-dependent diabetes using an injection pen: control, problems and patients preferences. Diabetes Res 1989; 11: 195-197.
16. Jehle P.M., Micheler C., Jehle D.R. et al. Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pens. Lancet 1999; 354: 1604-1607.
17. Brown A., Steel J.M., Duncan С. et al. An assessment of the adequacy of suspension of insulin in pen injectors. Diabet Med 2004; 21: 604-608.
18. Kaiser P., Maxeiner S., Weise A. et al. Assessment of the Mixing Efficiency of Neutral Protamine Hagedorn Cartridges. J Diabetes Sci Technol 2010; 4: 652-657.
Рецензия
Для цитирования:
. Инсулин НПХ. Эффективность перемешивания - эффективность дозирования. Проблемы Эндокринологии. 2011;57(4):56-60. https://doi.org/10.14341/probl201157456-60
For citation:
Nikonova T.V. NPH insulin. Effective mixing - effective dose regimen. Problems of Endocrinology. 2011;57(4):56-60. https://doi.org/10.14341/probl201157456-60

Контент доступен под лицензией Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).